XTRA Bitcoin Inc (CBTC)

[mailman69]

Read last Q report
6)
We are looking to raise the estimated $2million required to obtain US Food and Drug Administration approval of the
patented process for humans and to make the product available to our targeted markets. This process has continued
and has found some success following the release into the market of converted stocks. Interest in our shares has
continued with the conversion of further amounts of our long-term debt into Common Stock which has in turn
necessitated our increasing the authorized capital of the Company. Further increases are not deemed necessary at
present. Although we are still short of our targetted investment level which would allow trials to recommence, we have
been developing other long-term investment possibilities which will not come to fruition until the first quarter of 2015.
This delay has prevented us from pursuing the FDA approval, appointing our preferred investor relations and public
relations consultants and commissioning the new website.